Results 201 to 210 of about 28,882 (293)

Hybridization and Immunology in Animals: A Review. [PDF]

open access: yesEcol Evol
Graham CR   +3 more
europepmc   +1 more source

Fianlimab, a human lymphocyte activation gene‐3 monoclonal antibody, in combination with cemiplimab: Tumor‐specific expansion cohorts in advanced malignancies

open access: yesCancer, Volume 132, Issue 9, 1 May 2026.
Abstract Background The dose escalation phase of a first‐in‐human (FIH) study demonstrated acceptable safety and preliminary antitumor activity of fianlimab (anti‐lymphocyte activation gene‐3 [LAG‐3]) as monotherapy and in combination with cemiplimab (anti‐programmed cell death‐1 [PD‐1]). Here, the authors present safety and clinical activity data from
Tae Min Kim   +25 more
wiley   +1 more source

Combined Inhibition of ATR and Ribonucleotide Reductase Induces Synergistic Antineoplastic Activity in Osteosarcoma Cells

open access: yesCancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Osteosarcoma is the most common bone cancer in children and young adults. Its prognosis has not improved significantly since the introduction of the chemotherapy regimen established about 40 years ago, highlighting the need for new therapeutic strategies.
Natalie Aderhold   +5 more
wiley   +1 more source

Complex perishable technologies from the North American Great Basin reveal specialized Late Pleistocene adaptations. [PDF]

open access: yesSci Adv
Rosencrance RL   +13 more
europepmc   +1 more source

Just breathe [PDF]

open access: yes, 2014
Jones, Derek, Lotz, Nicole
core  

Advancing Pharmacometrics in Africa: Insights and Perspectives From the 2025 Pharmacometrics Africa Conference

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1216-1222, May 2026.
Pharmacometrics (PMX) in Africa has transitioned from foundational capacity‐building to job creation, scientific leadership, regulatory influence, and health innovation. To accelerate this progress, the 2025 Pharmacometrics Africa Conference (PMXAC‐2025) convened key stakeholders to consolidate the continental PMX community, review progress in local ...
Babatunde Ayodeji Adeagbo   +12 more
wiley   +1 more source

Critical Discourse Analysis in Corporate Reports: Legitimation Strategies in the Context of Environmental Controversies

open access: yesCorporate Social Responsibility and Environmental Management, Volume 33, Issue 3, Page 3563-3581, May 2026.
ABSTRACT This study examines the use of environmental disclosure as a strategic tool to manage legitimacy crises in a mining company, adopting critical discourse analysis (CDA) as the main methodology. Focusing on a case of environmental disaster, this research reveals how corporate narratives can be manipulated to minimize responsibility and reinforce
Renata Luiza de Castilho Rossoni   +1 more
wiley   +1 more source

Convergent targeting of FUNDC1‐dependent mitophagy sensitises and overcomes resistance to EGFR inhibition

open access: yesClinical and Translational Medicine, Volume 16, Issue 5, May 2026.
Nitidine synergises with osimertinib in EGFR‐mutant NSCLC. Nitidine and osimertinib converge on HIF‐1α/FUNDC1‐mediated mitophagy. ABCB6 is required for the nitidine‐associated HIF‐1α/FUNDC1 response. Adaptive FUNDC1 downregulation sensitises osimertinib‐resistant cells to nitidine monotherapy.
Fan Xu   +9 more
wiley   +1 more source

Registration of ‘Cougar’ Wheat

open access: yesCrop Science, 2001
P.S. Baenziger   +12 more
openaire   +2 more sources

Monkey Meltdowns: Do Tantrums Influence Maternal Investment in Bearded Capuchin Monkeys?

open access: yesDevelopmental Psychobiology, Volume 68, Issue 3, May 2026.
ABSTRACT Tantrums are widely discussed in human development literature and are typically defined as displays of frustration or anger. In behavioral ecology, they are hypothesized to function as a strategy for securing greater maternal investment. Infant primates often exhibit tantrums when their attempts to obtain maternal care are rejected.
Mábia B. Cera   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy